Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries

Benedicte Delcoigne; Lotta Ljung; Sella A. Provan; Bente Glintborg; Merete Lund Hetland; Kathrine Lederballe Gron; Ritva Peltomaa; Heikki Relas; Carl Turesson; Bjorn Gudbjornsson; Brigitte Michelsen; Johan Askling

doi:10.1136/annrheumdis-2021-221996

Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries

Benedicte Delcoigne, Lotta Ljung, Sella A. Provan, Bente Glintborg, Merete Lund Hetland, Kathrine Lederballe Gron, Ritva Peltomaa, Heikki Relas, Carl Turesson, Bjorn Gudbjornsson, Brigitte Michelsen, Johan Askling

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	Annals of the Rheumatic Diseases
Volym	81
Nummer	6
Sidor (från-till)	789-797
Antal sidor	9
ISSN	0003-4967
DOI	https://doi.org/10.1136/annrheumdis-2021-221996
Status	Publicerad - juni 2022
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3121 Allmänmedicin, inre medicin och annan klinisk medicin

Åtkomst av dokument

10.1136/annrheumdis-2021-221996

789.fullSlutlig publicerad version, 755 KBLicens: CC BY-NC

Citera det här

Delcoigne, B., Ljung, L., Provan, S. A., Glintborg, B., Hetland, M. L., Gron, K. L., Peltomaa, R., Relas, H., Turesson, C., Gudbjornsson, B., Michelsen, B., & Askling, J. (2022). Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries. Annals of the Rheumatic Diseases, 81(6), 789-797. https://doi.org/10.1136/annrheumdis-2021-221996

@article{6ed83031ab4d4f78a9edc0b15d3ad0f7,

title = "Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries",

keywords = "rheumatoid arthritis, tumor necrosis factor inhibitors, cardiovascular diseases, biological therapy, NECROSIS-FACTOR INHIBITORS, RHEUMATOID-ARTHRITIS, CARDIOVASCULAR EVENTS, REGISTER, MORTALITY, DISEASE, AGENTS, 3121 General medicine, internal medicine and other clinical medicine",

author = "Benedicte Delcoigne and Lotta Ljung and Provan, {Sella A.} and Bente Glintborg and Hetland, {Merete Lund} and Gron, {Kathrine Lederballe} and Ritva Peltomaa and Heikki Relas and Carl Turesson and Bjorn Gudbjornsson and Brigitte Michelsen and Johan Askling",

year = "2022",

month = jun,

doi = "10.1136/annrheumdis-2021-221996",

language = "English",

volume = "81",

pages = "789--797",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group Ltd",

number = "6",

}

Delcoigne, B, Ljung, L, Provan, SA, Glintborg, B, Hetland, ML, Gron, KL, Peltomaa, R, Relas, H, Turesson, C, Gudbjornsson, B, Michelsen, B & Askling, J 2022, 'Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries', Annals of the Rheumatic Diseases, vol. 81, nr. 6, s. 789-797. https://doi.org/10.1136/annrheumdis-2021-221996

Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs : results from four Nordic countries. / Delcoigne, Benedicte; Ljung, Lotta; Provan, Sella A. et al.

I: Annals of the Rheumatic Diseases, Vol. 81, Nr. 6, 06.2022, s. 789-797.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

TY - JOUR

T1 - Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs

T2 - results from four Nordic countries

AU - Delcoigne, Benedicte

AU - Ljung, Lotta

AU - Provan, Sella A.

AU - Glintborg, Bente

AU - Hetland, Merete Lund

AU - Gron, Kathrine Lederballe

AU - Peltomaa, Ritva

AU - Relas, Heikki

AU - Turesson, Carl

AU - Gudbjornsson, Bjorn

AU - Michelsen, Brigitte

AU - Askling, Johan

PY - 2022/6

Y1 - 2022/6

KW - rheumatoid arthritis

KW - tumor necrosis factor inhibitors

KW - cardiovascular diseases

KW - biological therapy

KW - NECROSIS-FACTOR INHIBITORS

KW - RHEUMATOID-ARTHRITIS

KW - CARDIOVASCULAR EVENTS

KW - REGISTER

KW - MORTALITY

KW - DISEASE

KW - AGENTS

KW - 3121 General medicine, internal medicine and other clinical medicine

U2 - 10.1136/annrheumdis-2021-221996

DO - 10.1136/annrheumdis-2021-221996

M3 - Article

VL - 81

SP - 789

EP - 797

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 6

ER -